Search

Your search keyword '"Robin, Kobbe"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Robin, Kobbe" Remove constraint Author: "Robin, Kobbe"
105 results on '"Robin, Kobbe"'

Search Results

1. Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany – A cross sectional study from the German Network University Medicine (NUM)

2. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

3. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

4. Reduced Humoral and Cellular Immune Response to Primary COVID-19 mRNA Vaccination in Kidney Transplanted Children Aged 5–11 Years

5. Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50

6. Data quality of reported child immunization coverage in 194 countries between 2000 and 2019.

7. Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study

8. Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series

9. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

10. Fatal COVID-19 in a Child with Persistence of SARS-CoV-2 Despite Extensive Multidisciplinary Treatment: A Case Report

11. The German National Registry of Primary Immunodeficiencies (2012–2017)

12. Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2

13. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies

14. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series

15. Neuropsychiatric Manifestations and Sleep Disturbances in Children and Adolescents Randomised to Dolutegravir-Based Antiretroviral Therapy vs Standard-of-Care in the Odyssey Trial

16. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

17. Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child

18. Mucha‐Habermann disease: a pediatric case report and proposal of a risk score

19. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome

20. Author response for 'Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients'

21. Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case Report

22. Detrimental

23. Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

24. Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants

27. [Updated recommendations on the treatment of infectious diseases in refugees in childhood and adolescence in Germany (situation as of 30 March 2022), registered as S1 guidelines (AWMF-Register Nr. 048-017)]

28. Long-Term Antibody Response to SARS-CoV-2 in Children

29. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

30. A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

31. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

32. [Recommendation for standardized medical care for children and adolescents with long COVID]

33. Novel Human Parvovirus 4 Genotype 3 in Infants, Ghana

34. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis

35. Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

36. HIV-Infektion im Kindesalter – Update

37. Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study

38. The value of open-source clinical science in pandemic response

39. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies

40. Q Fever in Young Children, Ghana

41. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history

42. Remdesivir, Sinus Bradycardia and Therapeutic Drug Monitoring in Children With Severe COVID-19

43. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS

44. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

45. Low and high infection dose transmissions of SARS-CoV-2 in the first COVID-19 clusters in Northern Germany

46. SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany

47. Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series

48. Infection Control and Virological Assessment of the First Cluster of COVID-19 in Northern Germany

49. Protozoen und Helminthen

50. Characterization of the Clinical and Immunologic Phenotype and Management of 157 Individuals with 56 Distinct Heterozygous NFKB1 Mutations

Catalog

Books, media, physical & digital resources